Hiren Kumar V Patel

Title: Hiren Kumar V Patel: Innovator in Pharmaceutical Processes

Introduction

Hiren Kumar V Patel is a notable inventor based in Fords, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of polypeptides and polymorphic forms of medications. With a total of 2 patents, Patel's work has implications for drug formulation and delivery.

Latest Patents

Patel's latest patents include innovative processes for preparing a polypeptide or pharmaceutically acceptable salt thereof, which comprises L-tyrosine, L-alanine, L-glutamate, and L-lysine. The polypeptide or its salt is preferably glatiramer acetate. Another significant patent involves the polymorph E of Olanzapine and the preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E. This invention provides methods for preparing polymorphic Olanzapine Form E using rapid crystallization and seeding, as well as methods for obtaining anhydrous Olanzapine Form I through step-wise drying.

Career Highlights

Hiren Kumar V Patel is currently employed at Sandoz AG, where he continues to advance his research in pharmaceutical sciences. His work is characterized by a commitment to improving drug formulations and enhancing therapeutic efficacy.

Collaborations

Patel collaborates with esteemed colleagues such as Anup Kumar Ray and Johannes Ludescher, contributing to a dynamic research environment that fosters innovation.

Conclusion

Hiren Kumar V Patel is a distinguished inventor whose work in pharmaceutical processes has the potential to impact drug development significantly. His contributions to the field are marked by a focus on innovative solutions for complex challenges in medication formulation.